The initiation of coverage by UBS with a Sell rating is likely to influence investor sentiment negatively, potentially leading to a short-term decline in RKT's stock price. The price target of $8.5 suggests that the analyst sees downside potential from the current market price, which could lead to bearish market action in the short term.